Literature DB >> 23054987

Effects of processing on the release profiles of matrix systems containing 5-aminosalicylic acid.

Anita Korbely1, András Kelemen, Péter Kása, Klára Pintye-Hódi.   

Abstract

The aim of this study was to investigate the influence of different processing methods on the profiles of 5-aminosalicylic acid dissolution from controlled-release matrix systems based on Eudragit® RL and Eudragit® RS water-insoluble polymers. The pure polymers and their mixtures were studied as matrix formers using different processing methods, i.e., direct compression, wet granulation of the active ingredient with the addition of polymer(s) to the external phase, wet granulation with water, and wet granulation with aqueous dispersions. In comparison with the directly compressed tablets, tablets made by wet granulation with water demonstrated a 6-19% increase in final drug dissolution, whereas when polymers were applied in the external phase during compression, a 0-13% decrease was observed in the amount of drug released. Wet granulation with aqueous polymer dispersions delayed the release of the drug; this was especially marked (a 54-56% decrease in drug release) in compositions, which contained a high amount of Eudragit RL 30D. The release profiles were mostly described by the Korsmeyer-Peppas model or the Hopfenberg model.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23054987      PMCID: PMC3513469          DOI: 10.1208/s12249-012-9861-9

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  10 in total

Review 1.  Modeling and comparison of dissolution profiles.

Authors:  P Costa; J M Sousa Lobo
Journal:  Eur J Pharm Sci       Date:  2001-05       Impact factor: 4.384

Review 2.  A flexible technology for the linear, pulsatile and delayed release of drugs, allowing for easy accommodation of difficult in vitro targets.

Authors:  U Conte; L Maggi
Journal:  J Control Release       Date:  2000-02-14       Impact factor: 9.776

Review 3.  Formulation aspects in the development of osmotically controlled oral drug delivery systems.

Authors:  Rajan K Verma; Divi Murali Krishna; Sanjay Garg
Journal:  J Control Release       Date:  2002-02-19       Impact factor: 9.776

4.  Mechanistic evaluation of the effect of thermal-treating on Eudragit RS matrices.

Authors:  Shirzad Azarmi; Fatemeh Ghaffari; Raimar Löbenberg; Ali Nokhodchi
Journal:  Farmaco       Date:  2005-10-11

Review 5.  Gastroretentive delivery systems: a mini review.

Authors:  R Talukder; R Fassihi
Journal:  Drug Dev Ind Pharm       Date:  2004       Impact factor: 3.225

6.  Absorption, metabolism, and excretion of salicylazosulfapyridine in man.

Authors:  H Schröder; D E Campbell
Journal:  Clin Pharmacol Ther       Date:  1972 Jul-Aug       Impact factor: 6.875

7.  Distribution studies of salicylazosulfapyridine and its metabolites.

Authors:  M A Peppercorn; P Goldman
Journal:  Gastroenterology       Date:  1973-02       Impact factor: 22.682

8.  Analysis of Fickian and non-Fickian drug release from polymers.

Authors:  N A Peppas
Journal:  Pharm Acta Helv       Date:  1985

9.  Evaluation of drug release from coated pellets based on isomalt, sugar, and microcrystalline cellulose inert cores.

Authors:  Nikolett Kállai; Oliver Luhn; Judit Dredán; Kristóf Kovács; Miléna Lengyel; István Antal
Journal:  AAPS PharmSciTech       Date:  2010-03-17       Impact factor: 3.246

10.  Kinetics of 5-aminosalicylic acid after jejunal instillation in man.

Authors:  O Haagen Nielsen; S Bondesen
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

  10 in total
  2 in total

Review 1.  Power of the Dissolution Test in Distinguishing a Change in Dosage Form Critical Quality Attributes.

Authors:  Vivian A Gray
Journal:  AAPS PharmSciTech       Date:  2018-10-22       Impact factor: 3.246

2.  Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets.

Authors:  Sileshi Belew; Sultan Suleman; Markos Duguma; Henok Teshome; Evelien Wynendaele; Luc Duchateau; Bart De Spiegeleer
Journal:  Malar J       Date:  2020-04-07       Impact factor: 2.979

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.